Literature DB >> 9315780

Progress toward global measles control and elimination, 1990-1996.

.   

Abstract

In 1989, the World Health Assembly resolved to reduce measles morbidity by 90% and measles mortality by 95% by 1995, compared with disease burden during the prevaccine era. By 1996, the estimated incidence and death rates for measles worldwide were reduced by 78% and 88%, respectively. In 1990, the World Summit for Children adopted a goal of vaccinating 90% of children against measles by 2000. However, routine measles vaccination coverage has remained relatively stable since 1990, and an estimated 1 million children continue to die from this preventable disease each year. During the 1990s, the widespread use of innovative measles-control strategies in the Region of the Americas and countries such as Mongolia, South Africa, and the United Kingdom demonstrated that high-level measles control and even interruption of transmission is feasible over large geographic areas. This report updates the status of measles control and elimination worldwide and includes disease surveillance and vaccination coverage data received by the World Health Organization (WHO) headquarters in Geneva, Switzerland, as of August 29, 1997. These findings indicate that, in some regions, substantial progress has been made to control and interrupt measles transmission; in others, measles continues to cause high morbidity and mortality because of failure to implement measles-control strategies.

Entities:  

Keywords:  Age Factors; Child; Child Mortality; Demographic Factors; Diseases; Incidence; International Agencies; Measles--prevention and control; Measurement; Morbidity; Mortality; Organizations; Population; Population Characteristics; Population Dynamics; Prevalence; Research Methodology; Un; Viral Diseases; Who; World; Youth

Mesh:

Year:  1997        PMID: 9315780

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  4 in total

1.  Measles in a hilly hamlet of northern India.

Authors:  Bhavneet Bharti; Sahul Bharti
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

2.  Spatial clustering of measles cases during endemic (1998-2002) and epidemic (2010) periods in Lusaka, Zambia.

Authors:  Jessie Pinchoff; James Chipeta; Gibson Chitundu Banda; Samuel Miti; Timothy Shields; Frank Curriero; William John Moss
Journal:  BMC Infect Dis       Date:  2015-03-10       Impact factor: 3.090

3.  Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.

Authors:  Piyanit Tharmaphornpilas; Pornsak Yoocharean; Aim-Orn Rasdjarmrearnsook; Apiradee Theamboonlers; Yong Poovorawan
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

4.  Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.

Authors:  Romanee Chaiwarith; Jutarat Praparattanapan; Khanuengnit Nuket; Wilai Kotarathitithum; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2016-04-30       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.